Mylan buys Abbott generics
July 15, 2014Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan
Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …
UK digital health showcased in China
July 15, 2014Medical Communications, Sales and Marketing China, Shanghai, UK, britain, comms, digital, health
The British government is showcasing its most promising digital health firms at a new centre in China. The “Healthcare is …
Baxter takes R&D head from Merck Serono
July 15, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, baxter, john orloff
Baxter International has appointed Dr John Orloff as its vice president and global head of R&D development for Baxter BioScience. …
Contraceptive microchip tipped to revolutionise birth control
July 14, 2014Medical Communications, Sales and Marketing Bill Gates, MIT, contraceptive, device, implant, microchips
IT start-up company MicroCHIPS is developing a radical new contraceptive in the form of a microchip that is implanted under …
Sun Pharma recalls 40,000 bottles
July 14, 2014Manufacturing and Production Caraco Pharmaceutical Laboratories, FDA, Pfizer/Wyeth’s Effexor XR, Sun Pharma, antidepressant, recall
India-based manufacturer Sun Pharmaceutical Industries is recalling more than 40,000 bottles of its antidepressant venlafaxine hydrochloride, the US regulator has …
AbbVie a step closer to Shire takeover
July 14, 2014Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover
Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …
Roche combination drug for melanoma impresses
July 14, 2014Research and Development, Sales and Marketing GSK, Roche, Yervoy, braf, mekinist. MEK, melanoma
Roche’s investigational melanoma drug cobimetinib has helped late-stage patients live longer when used in combination with its established skin cancer …
GSK investigator charged in China
July 14, 2014Medical Communications, Sales and Marketing China, GSK, Witty, bribery, humphrey, sex tape
The man who GlaxoSmithKline paid to investigate an illegally produced sex tape of one its senior employees has been charged …
Working Life: Celgene’s Rob Moore
July 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Working Life, rob moore
How did you find your way into your current role? I joined the pharmaceutical industry almost 20 years ago with …
ProStrakan pays £230m for Archimedes
July 14, 2014Sales and Marketing Archimedes, Cancer, ProStrakan, pain, pecfent
The ProStrakan Group is to looking to expand its offerings via a payment of £230 million for Archimedes Pharma. The …
Two hires at Cello Health Communications
July 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, cello health, davies, yates
Healthcare comms agency Cello Health Communications has made two senior appointments at its London office. Anthea Davies (pictured) joins the …
Bayer in Oxford tie-up
July 11, 2014Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university
Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …
BMS to make Opdivo submission
July 11, 2014Sales and Marketing BMS, Cancer, EMA, FDA, ono, opdivo, pd-1
Bristol-Myers Squibb is to submit cancer treatment Opdivo to the US authorities after the drug received its first approval in …
QRxPharma announces several resignations
July 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, PACE, QRxPharma, farrell, quinn
Australian pharma development firm QRxPharma has confirmed that its chairman Dr Peter Farrell and director Dr Gary Pace have resigned. …
Servier fined €331m by European Commission
July 10, 2014Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva
The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …
EMA delays trial transparency – again
July 10, 2014Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency
The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …
NICE ‘yes’ for Selincro
July 10, 2014Sales and Marketing Lundbeck, NHS, NICE, alcohol, nalmefene, selincro
Lundbeck has received a lift from UK drugs pricing watchdog NICE as it has recommended the firm’s alcohol dependency pill …
Glide Pharma makes two senior hires
July 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Glide Pharma, Richard Bungay, Tony Mills
Oxford-based development and device firm Glide Pharma has appointed Richard Bungay as its chief financial officer (CFO) and Dr Tony …
Alzheimer’s test ‘87% accurate’, say reports
July 9, 2014Sales and Marketing Alzheimer's, Alzheimer’s, Alzheimer’s & dementia, Cameron, NHS, NHS Choices, dementia
NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s …
Celebrities back Bowel Cancer UK’s screening call
July 9, 2014Medical Communications, Sales and Marketing bowel cancer uk, celebrities, screening
A range of celebrities, including Sir Chris Hoy, Benedict Cumberbatch, Ricky Gervais and Ben Richards, have pledged support to Bowel …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
